Roffman Miller Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.63M |
| 2 |
Johnson Controls International
JCI
|
+$964K |
| 3 |
Ametek
AME
|
+$955K |
| 4 |
Adobe
ADBE
|
+$793K |
| 5 |
Kimberly-Clark
KMB
|
+$728K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.97M |
| 2 |
Microsoft
MSFT
|
+$3.76M |
| 3 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$3.42M |
| 4 |
Procter & Gamble
PG
|
+$3.25M |
| 5 |
Intel
INTC
|
+$2.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.83% |
| 2 | Industrials | 14.56% |
| 3 | Consumer Staples | 14.2% |
| 4 | Healthcare | 11.85% |
| 5 | Consumer Discretionary | 10.91% |
Similar funds
Roffman Miller Associates's Q3 2020 Portfolio in Review
As of Q3 2020, Roffman Miller Associates held 150 positions worth $1.03B, up 2.7% from $1.01B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Roffman Miller Associates withdrew a net $53.2M in Q3 2020, closing 75 positions and reducing 39 holdings. Its most notable exit was Tabula Rasa HealthCare, Inc. Common Stock, an estimated $3.42M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Roffman Miller Associates added an estimated $1.63M to Merck.
- Roffman Miller Associates added most to Merck in Q3 2020, an estimated $1.63M increase.
- Roffman Miller Associates's biggest Q3 2020 reduction was ExxonMobil, cutting an estimated $3.97M.
- Roffman Miller Associates fully exited Tabula Rasa HealthCare, Inc. Common Stock in Q3 2020, selling an estimated $3.42M.
- Roffman Miller Associates's ten largest holdings make up 40% of its $1.03B portfolio in Q3 2020.
- Roffman Miller Associates opened 0 new positions and closed 75 in Q3 2020.
- Roffman Miller Associates's portfolio value rose 2.7% quarter-over-quarter to $1.03B.
Based on Roffman Miller Associates's 13F filing for Q3 2020, filed 6 Nov 2020.